Lupe Contreras, NP
Nurse Practitioner · Phoenix, AZNPI 1588830749
Payments from drug & device makers
Across 65 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$499
- Johnson & Johnson$281
- Madrigal Pharmaceuticals$149
- Takeda Pharmaceuticals U.S.A., Inc.$133
- Neurocrine Biosciences, Inc.$108
- Indivior Inc.$83
- plus $261 from 8 others
What the payments were for
- Food & beverage$1,516100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 25 | $499 |
| Johnson & Johnson(2 entities) | 9 | $281 |
| Madrigal Pharmaceuticals | 2 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $133 |
| Neurocrine Biosciences, Inc. | 5 | $108 |
| Indivior Inc. | 4 | $83 |
| Abbott | 4 | $77 |
| AbbVie | 4 | $76 |
| Sanofi | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Lucid Diagnostics Inc. | 1 | $18 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$483
- ARISTADA$479
- Tremfya$124
- REZDIFFRA$122
- ARISTADA INITIO$120
How this compares
$1,516 in reported general payments places this provider in the 85th percentile of 1,719 nurse practitioner providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 77 | $1,150 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 50 | $781 |
| Atorvastatin Calcium | 34 | $627 |
| Simvastatin | 14 | $270 |
| Metformin Hcl | 20 | $270 |
| Lisinopril | 28 | $241 |
| Levothyroxine Sodium | 15 | $238 |
| Pantoprazole Sodium | 16 | $226 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 14 | $207 |
| Omeprazole | 18 | $191 |
| Losartan Potassium | 13 | $92 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Phoenix
- Helena In't VeldPhoenix$64K
- Dustin NickersonPhoenix$39K
- Ryan MobleyPhoenix$22K
- Anita PalandriPhoenix$20K
- Kristina WernerPhoenix$19K
- Miranda IsomPhoenix$17K
- Catherine LynnPhoenix$16K
- Edith GazoPhoenix$15K
- Dora QuanPhoenix$14K
- Rachael BennettPhoenix$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.